Premium
Expression of CD30 (Ber‐H2) in nasopharyngeal carcinoma, undifferentiated type and lymphoepithelioma‐like carcinoma. A comparison study with anaplastic large cell lymphoma
Author(s) -
Kneile J R,
Tan G,
Suster S,
Wakely P E
Publication year - 2006
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/j.1365-2559.2006.02449.x
Subject(s) - cd30 , pathology , anaplastic large cell lymphoma , lymphoma , lymphoepithelioma , nasopharyngeal carcinoma , medicine , large cell , immunohistochemistry , lymphoepithelioma like carcinoma , anaplastic carcinoma , carcinoma , epstein–barr virus , adenocarcinoma , radiation therapy , cancer , immunology , virus
Aims : Undifferentiated nasopharyngeal non‐keratinizing carcinoma (UNPC), formerly known as lymphoepithelioma, frequently metastasizes at an early stage to regional lymph nodes and, thus, may be difficult to distinguish from Hodgkin's lymphoma (HL) or anaplastic large cell lymphoma (ALCL). CD30 expression is a useful diagnostic stain in both HL and ALCL, but its expression in UNPC deserves clarification. The aim of this study was to evaluate CD30 expression in UNPC and lymphoepithelioma‐like carcinoma (LELC) from other anatomic locations and compare it with ALCL and squamous cell carcinoma (SCC). Methods and results : CD30 immunoreactivity was examined in 38 cases of primary or metastatic UNPC, six cases of LELC, 10 cases of SCC and seven cases of ALCL. CD30 immunoreactivity was observed in four of 38 (10.5%) cases of UNPC. CD30 staining was absent in all cases of LELC (0/6) and SCC (0/10). All cases of ALCL (7/7) were strongly positive for CD30. Conclusions : The majority of cases of UNPC are immunohistochemically negative for CD30; however, a small subset of cases expresses CD30 antigen. These findings provide additional evidence that CD30 expression is not restricted to neoplasms of lymphoid origin. This should be taken into consideration when interpreting CD30 immunohistology and the possibility of UNPC.